Estrategias Combinadas en Inmunoterapia Traslacional
ITC
National Institute of Allergy and Infectious Diseases
Bethesda, Estados UnidosPublicaciones en colaboración con investigadores/as de National Institute of Allergy and Infectious Diseases (1)
2021
-
DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type i conventional dendritic cells
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 5